Tango Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Tango Therapeutics Depreciation & Amortization Growth & History (TNGX)
Tango Therapeutics's depreciation and amortization was $2.3M for fiscal 2025.
View full Tango Therapeutics company overviewTango Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.3M | −$218,000 | −8.72% |
| 2024 | 2024-12-31 | $2.5M | $84,000 | +3.48% |
| 2023 | 2023-12-31 | $2.4M | $807,000 | +50.19% |
| 2022 | 2022-12-31 | $1.6M | $711,000 | +79.26% |
| 2021 | 2021-12-31 | $897,000 | $179,000 | +24.93% |
| 2020 | 2020-12-31 | $718,000 | — | — |
Tango Therapeutics quarterly depreciation and amortization
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $425,000 | −$200,000 | −32.00% |
| Q1 2026 | 2026-03-31 | $463,000 | −$159,000 | −25.56% |
| Q4 2025 | 2025-12-31 | $479,000 | — | — |
| Q3 2025 | 2025-09-30 | $555,000 | −$67,000 | −10.77% |
| Q2 2025 | 2025-06-30 | $625,000 | −$7,000 | −1.11% |
| Q1 2025 | 2025-03-31 | $622,000 | −$3,000 | −0.48% |
| Q3 2024 | 2024-09-30 | $622,000 | $9,000 | +1.47% |
| Q2 2024 | 2024-06-30 | $632,000 | $28,000 | +4.64% |
| Q1 2024 | 2024-03-31 | $625,000 | $44,000 | +7.57% |
| Q3 2023 | 2023-09-30 | $613,000 | $196,000 | +47.00% |
| Q2 2023 | 2023-06-30 | $604,000 | $292,000 | +93.59% |
| Q1 2023 | 2023-03-31 | $581,000 | $272,000 | +88.03% |
| Q3 2022 | 2022-09-30 | $417,000 | $217,000 | +108.50% |
| Q2 2022 | 2022-06-30 | $312,000 | $100,000 | +47.17% |
| Q1 2022 | 2022-03-31 | $309,000 | $105,000 | +51.47% |
| Q3 2021 | 2021-09-30 | $200,000 | $0 | 0.00% |
| Q2 2021 | 2021-06-30 | $212,000 | — | — |
| Q1 2021 | 2021-03-31 | $204,000 | — | — |
| Q3 2020 | 2020-09-30 | $200,000 | — | — |
Tango Therapeutics depreciation and amortization trends
Over the last five fiscal years, Tango Therapeutics's depreciation and amortization increased from $718,000 to $2.3M, a change of $1.6M. The latest reported quarter, Q2 2026, shows $425,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tango Therapeutics source filings ↗